LynchMEWareMA.Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J Neuroimmune Pharmacol2015; 10(2): 293–301.
2.
WhitingPFWolffRFDeshpandeS, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA2015; 313(24): 2456–2473.
3.
WongSSWilensTE.Medical cannabinoids in children and adolescents: a systematic review. Pediatrics2017; 140(5): e20171818.
4.
MeierMHCaspiAAmblerA, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A2012; 109(40): E2657–E2664.
5.
D’SouzaDCSewellRARanganathanM.Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci2009; 259(7): 413–431.
6.
KuhlenMHoellJIGagnonG, et al. Effective treatment of spasticity using dronabinol in pediatric palliative care. Eur J Paediatr Neurol2016; 20(6): 898–903.
7.
RudichZStinsonJJeavonsM, et al. Treatment of chronic intractable neuropathic pain with dronabinol: case report of two adolescents. Pain Res Manag2003; 8(4): 221–224.
8.
AbramsDICoueyPShadeSB, et al. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther2011; 90(6): 844–851.
9.
NarangSGibsonDWasanAD, et al. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain2008; 9(3): 254–264.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
